Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 15;10(2):81.
doi: 10.3390/jcdd10020081.

Elevated Levels of Neutrophil-to Monocyte Ratio Are Associated with the Initiation of Paroxysmal Documented Atrial Fibrillation in the First Two Months after Heart Transplantation: A Uni-Institutional Retrospective Study

Dragos-Florin Baba  1   2 , Horatiu Suciu  1   3 , Calin Avram  4 , Manuela Gyorgy  5 , Alina Danilesco  2 , Laurentiu Huma  1   2 , Ileana Anca Sin  2
Affiliations

Elevated Levels of Neutrophil-to Monocyte Ratio Are Associated with the Initiation of Paroxysmal Documented Atrial Fibrillation in the First Two Months after Heart Transplantation: A Uni-Institutional Retrospective Study

Dragos-Florin Baba et al. J Cardiovasc Dev Dis. .

Abstract

Background: Heart transplantation represents the treatment for patients with end-stage heart failure (HF) being symptomatic despite optimal medical therapy. We investigated the role of NMR (neutrophil-to-monocyte ratio), NLR (neutrophil-to-lymphocyte ratio), NPR (neutrophil-to-platelet ratio), NWR (neutrophil-to-white cells ratio), MLR (monocyte-to-lymphocyte ratio), PLR (platelet-to-lymphocyte ratio), MWR (neutrophil-to-white cells ratio), and LWR (lymphocyte-to-white cells ratio) at the same cut-off values previously studied, to predict complications after heart transplant within 2 months after surgery.

Methods: From May 2014 to January 2021, was included 38 patients in our study from the Cardiovascular and Transplant Emergency Institute of Târgu Mureș.

Results: Preoperative NMR > 8.9 (OR: 70.71, 95% CI: 3.39-1473.64; p = 0.006) was a risk factor for the apparition of post-operative paroxysmal atrial fibrillation (Afib). In contrast, preoperative MWR > 0.09 (OR: 0.04, 95% CI: 0.003-0.58; p = 0.0182) represented a protective factor against AFib, but being the risk of complications of any cause (OR: 14.74, 95% CI: 1.05-206.59, p = 0.0458).

Conclusion: Preoperative elevated levels of NMR were associated with the apparition of documented AFib, with high levels of MWR as a protective factor. High MWR was a risk factor in developing complications of any cause in the first 2 months after heart transplantation.

Keywords: atrial fibrillation; heart transplant; inflammation; monocyte-to-white cells ratio; neutrophil-to-monocyte ratio.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Patient selection and follow-up.
Figure 2
Figure 2
Distribution of patients based on cut-off levels of NMR and MWR.
See this image and copyright information in PMC

References

    1. Alraies M.C., Eckman P. Adult heart transplant: Indications and outcomes. J. Thorac. Dis. 2014;6:1120–1128. doi: 10.3978/j.issn.2072-1439.2014.06.44. - DOI - PMC - PubMed
    1. Brink J.G., Hassoulas J. The first human heart transplant and further advances in cardiac transplantation at Groote Schuur Hospital and the University of Cape Town—With reference to: The operation. A human cardiac transplant: An interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. Cardiovasc. J. Afr. 2009;20:31–35. - PMC - PubMed
    1. Stehlik J., Leah B.E., Anna Y.K., Christian B., Jason D.C., Fabienne D., Richard K., Axel O.R., Marshall I.H. The Registry of the International Society for Heart and Lung Transplantation: Twenty-Eighth Adult Heart Transplant Report—2011. J. Heart Lung Transplant. 2011;30:1078–1094. doi: 10.1016/j.healun.2011.08.003. - DOI - PubMed
    1. Anyanwu A.C. Intrathoracic Organ Transplantation in the United Kingdom 1995-99: Results from the UK Cardiothoracic Transplant Audit. Heart. 2002;87:449–454. doi: 10.1136/heart.87.5.449. - DOI - PMC - PubMed
    1. Ruparelia N., Joshua T.C., Edward A.F., Robin P.C. Inflammatory Processes in Cardiovascular Disease: A Route to Targeted Therapies. Nat. Rev. Cardiol. 2017;14:314. doi: 10.1038/nrcardio.2017.33. - DOI - PubMed